The Journal of laryngology and otology · 2024
The management of non-tuberculous mycobacteria cervicofacial lymphadenitis: a survey of UK paediatric tertiary hospitals.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Williams Timothy, McCaffer Craig, Blackmore Kate
Аннотация
OBJECTIVES: Management of paediatric non-tuberculous mycobacteria cervicofacial lymphadenitis (NTMCL) is variable without standard practice in the U.K. We undertook a survey to evaluate current U.K. practice in tertiary paediatric units.
METHODS: A survey of twenty-one tertiary paediatric centres to evaluate NTMCL management.
RESULTS: We received over 90% response rate. Only 21% have local guidelines, with the majority believing that written national guidance would improve management. Surgery is the most common management choice (69%), with a more limited procedure if skin is involved and/or in proximity to important structures. Observation alone is favoured (32%) when there is no skin involvement but in close proximity to the facial nerve. When treated medically, rifampicin and clarithromycin for 3 months was the commonest choice. Over 25% of respondents state their management has changed following previous adverse outcomes within their own practice or department.
CONCLUSION: This survey consolidates the current management of NTMCL in U.K. tertiary paediatric units.
METHODS: A survey of twenty-one tertiary paediatric centres to evaluate NTMCL management.
RESULTS: We received over 90% response rate. Only 21% have local guidelines, with the majority believing that written national guidance would improve management. Surgery is the most common management choice (69%), with a more limited procedure if skin is involved and/or in proximity to important structures. Observation alone is favoured (32%) when there is no skin involvement but in close proximity to the facial nerve. When treated medically, rifampicin and clarithromycin for 3 months was the commonest choice. Over 25% of respondents state their management has changed following previous adverse outcomes within their own practice or department.
CONCLUSION: This survey consolidates the current management of NTMCL in U.K. tertiary paediatric units.